Continuing weak margins due to staffing struggles, recent generic introductions, and decreasing reimbursements remain the leading drivers of the poor results
Illumina sees the value of genomic testing growing and consumer adoption at its beginning stage
EVERSANA, while being formed, realized that its customers needed patient-centered, value-based care
Reduce Health Costs By Nurturing The Sickest? A Much-Touted Idea Disappoints
Health policy decisions will be impacted by the multi-year shifting of federal controls over select healthcare-related decision-making has emboldened state legislatures to act when Congress has been unable to do so.
Pharmacist partnerships are helping genetic testing companies to grow
Kroger and Walgreens expanding their relationship to compete against larger companies
Investment in Digital Therapeutics is expanding rapidly with industry stakeholders working to develop their strategies for success